A reference post rather than a discussion. Corrections are the point; I would rather this be right than mine. It is about hydration and electrolytes, and it is deliberately narrow — everything I am not confident about is marked as such.
Two things drive this: people drink less because drinking makes them feel full, and they restrict salt at the same time as calories without noticing. The result reads as fatigue, headache, cramp and light-headedness on standing, all of which get blamed on the drug. Fluid plus sodium fixes most of it within a day, which is also how you can tell that is what it was.
The kidney-stone risk is the reason to take it seriously rather than just uncomfortable. Concentrated urine over months is a stone-forming condition.
The test is quick: add fluid and salt for two days and see whether the symptom goes. If it does not, it was not hydration and it is worth a panel.
What I am after is why hydration goes wrong on this specifically, given that nobody is telling us to drink less. I have searched first, so if this is covered somewhere point me at it and I will read it.
JennaRN said:Two things drive this: people drink less because drinking makes them feel full, and they restrict salt at the same time as calories without noticing.
Agreed, and cold chain is the underrated risk on long routes. A shipment held at a border for a week has had a temperature excursion whether or not it arrives.
JennaRN said:Two things drive this: people drink less because drinking makes them feel full, and they restrict salt at the same time as calories without noticing.
Pushing back on JennaRN here. Import rules are jurisdiction-specific and this board keeps giving US-shaped answers to non-US questions. What is a personal-import allowance in one country is a controlled-import offence in another.
If somebody has the primary source to hand I would rather cite it than paraphrase it.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsThis one has a reasonably settled answer, so here it is. The variables that decide how a cross-border order goes are declaration wording, the destination country's import rules for prescription medicines, and whether the shipment looks commercial. Personal-import allowances exist in some jurisdictions and not in others, and where they exist they are usually conditional on a prescription and a quantity limit. The failure mode is normally a seizure notice rather than anything worse, and a reshipment policy is the thing worth confirming before ordering rather than after.
MikeFit_NJ said:Agreed, and cold chain is the underrated risk on long routes.
Adding a me-too, because a thread of one person's experience is not much use.